Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2019 Jul 24:10:1754.
doi: 10.3389/fimmu.2019.01754. eCollection 2019.

The Kuwait National Primary Immunodeficiency Registry 2004-2018

Affiliations
Clinical Trial

The Kuwait National Primary Immunodeficiency Registry 2004-2018

Waleed Al-Herz et al. Front Immunol. .

Abstract

Objective: To present the report from the Kuwait National Primary Immunodeficiency Registry between 2004 and 2018. Methods: The patients were followed prospectively between January 2004 and December 2018 and their collected data included sociodemographic, diagnosis, clinical presentation, laboratory tests, and treatment. Results: A total of 314 PID patients (165 males and 149 females) were registered during the study period. Most of the patients (n = 287, 91.4%) were Kuwaiti nationals and the prevalence among Kuwaitis was 20.27/100,000 with a cumulative incidence of 24.96/100,000 Kuwaitis. The distribution of the patients according to PID categories was as follow: immunodeficiencies affecting cellular and humoral immunity, 100 patients (31.8%); combined immunodeficiencies with associated syndromic features, 68 patients (21.7%); predominantly antibody deficiencies, 56 patients (17.8%); diseases of immune dysregulation, 47 patients (15%); congenital defects of phagocyte number or function, 20 patients (6.4%); autoinflammatory disorders, 1 patient (0.3%); and complement deficiencies, 22 patients (7%). The mean age of the patients at onset of symptoms was 26 months while the mean age at diagnosis was 53 months and the mean delay in diagnosis was 27 months. Most of the patients (n = 272, 86%) had onset of symptoms before the age of 5 years. Parental consanguinity rate within the registered patients was 78% and a positive family history of PID was noticed in 50% of the patients. Genetic testing was performed in 69% of the patients with an overall diagnostic yield of 90%. Mutations were identified in 46 different genes and more than 90% of the reported genetic defects were transmitted by an autosomal recessive pattern. Intravenous immunoglobulins and stem cell transplantation were used in 58% and 25% of the patients, respectively. There were 81 deaths (26%) among the registered patients with a mean age of death of 25 months. Conclusions: PID is not infrequent in Kuwait and the reported prevalence is the highest in the literature with increased proportion of more severe forms. Collaborative efforts including introduction of newborn screening should be implemented to diagnose such cases earlier and improve the quality of life and prevent premature deaths.

Keywords: consanguinity; epidemiology; immunodeficiency; incidence; mortality; prevalence; registry.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The number (n = 314) and annual distribution of registered patients in KNPIDR between 2004 and 2018.
Figure 2
Figure 2
The distribution of patients registered in KNPIDR according to PID categories.
Figure 3
Figure 3
Age distribution of patients registered in KNPIDR according to the onset and diagnosis age.
Figure 4
Figure 4
The number (n = 62) and annual distribution of original research papers published in MEDLINE with patients' data gathered from KNPIDR between 2008 and 2018.

References

    1. Picard C, Bobby Gaspar H, Al-Herz W, Bousfiha A, Casanova JL, Chatila T, et al. . International union of immunological societies: 2017 primary immunodeficiency diseases committee report on inborn errors of immunity. J Clin Immunol. (2018) 38:96–128. 10.1007/s10875-017-0464-9 - DOI - PMC - PubMed
    1. Seidel MG, Kindle G, Gathmann B, Quinti I, Buckland M, van Montfrans J, et al. . The European Society for Immunodeficiencies (ESID) registry working definitions for the clinical diagnosis of inborn errors of immunity. J Allergy Clin Immunol Pract. (2019) 7:1763–70. 10.1016/j.jaip.2019.02.004 - DOI - PubMed
    1. Al-Tamemi S, Naseem SU, Al-Siyabi N, El-Nour I, Al-Rawas A, Dennison D, et al. . Primary immunodeficiency diseases in oman: 10-year experience in a tertiary care hospital. J Clin Immunol. (2016) 36:785–92. 10.1007/s10875-016-0337-7 - DOI - PubMed
    1. Errante PR, Franco JL, Espinosa-Rosales FJ, Sorensen R, Condino-Neto A. Advances in primary immunodeficiency diseases in Latin America: epidemiology, research, and perspectives. Ann N Y Acad Sci. (2012) 1250:62–72. 10.1111/j.1749-6632.2011.06289.x - DOI - PubMed
    1. Gathmann B, Goldacker S, Klima M, Belohradsky BH, Notheis G, Ehl S, et al. . The German national registry for primary immunodeficiencies (PID). Clin Exp Immunol. (2013) 173:372–80. 10.1111/cei.12105 - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources